Saturday, 4 March 2023

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) at American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology


https://worldnewsguru.us/business/89bio-presents-new-analysis-of-data-from-phase-2-entrigue-trial-of-pegozafermin-in-patients-with-severe-hypertriglyceridemia-shtg-at-american-college-of-cardiologys-annual-scientific-session-t/616360/

No comments:

Post a Comment